SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-023075
Filing Date
2023-05-05
Accepted
2023-05-05 07:01:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20008400x3_defa14a.htm DEFA14A 15403
2 ny20008400x3-nc_01.jpg GRAPHIC 1817577
3 ny20008400x3-nc_02.jpg GRAPHIC 1400971
  Complete submission text file 0001140361-23-023075.txt   4136381
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-11460 | Film No.: 23891174
SIC: 2834 Pharmaceutical Preparations